Should You Buy Cansortium Inc (CNTMF) in Drug Manufacturers

Cansortium Inc (CNTMF) is near the middle in its industry group according to InvestorsObserver. CNTMF gets an overall rating of 49. That means it scores higher than 49 percent of stocks. Cansortium Inc gets a 66 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 92 out of 148 industries.

CNTMF has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on CNTMF!

See Full CNTMF Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Cansortium Inc Stock Today?

Cansortium Inc (CNTMF) stock has gained 8.33% while the S&P 500 is lower by -0.39% as of 1:12 PM on Monday, Apr 1. CNTMF is up $0.02 from the previous closing price of $0.21 on volume of 549,776 shares. Over the past year the S&P 500 has risen 26.90% while CNTMF is up 187.50%. CNTMF lost -$0.09 per share the over the last 12 months. Click Here to get the full Stock Report for Cansortium Inc stock.